Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Università degli Studi di Ferrara
With
GlaxoSmithKline
Age
50–80
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Sixty stable moderate COPD patients (Global Initiative for Chronic Obstructive Lung Disease (GOLD) stage 2) requiring regular treatment with long-acting bronchodilators, according to international guidelines.
GOLD stage 2 COPD patients will be enrolled providing they were steroid-free for the last 4 months
You may not be if
Atopy
Asthma
Concomitant lung diseases (e.g. lung cancer)
Acute infections of the respiratory tree in the previous 3 months including COPD exacerbation.
Clareo Health | Effects of Inhaled Corticosteroids on Sputum Bacterial Load in COPD
